Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Amrinone-induced thrombocytopenia.

J Ansell, C Tiarks, J McCue

Archives of Internal Medicine

|May 1, 1984

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

It's time to improve antithrombotic therapy! A global perspective for antithrombotic stewardship.

European journal of internal medicine·2026

Same author

Safety of maintaining elective and emergency surgery during the COVID-19 pandemic with the introduction of a Protected Elective Surgical Unit (PESU): A cross-specialty evaluation of 30-day outcomes in 9,925 patients undergoing surgery in a University Health Board.

Surgery open science·2022

Same author

Paving the way for application of next generation risk assessment to safety decision-making for cosmetic ingredients.

Regulatory toxicology and pharmacology : RTP·2021

Same author

Variation in training requirements within general surgery: comparison of 23 countries.

BJS open·2021

Same author

Facing the Ethical Challenges: Consumer Involvement in COVID-19 Pandemic Research.

Journal of bioethical inquiry·2020

Same author

Safe management of surgical smoke in the age of COVID-19.

The British journal of surgery·2020

Same journal

Elevated CK-MB With Normal Total Creatine Kinase Levels in Patients Undergoing Maintenance Hemodialysis-Reply.

Archives of internal medicine·2017

Same journal

Occult Carbon Monoxide Poisoning-Reply.

Archives of internal medicine·2017

Same journal

Acquired Immune Deficiency Syndrome-Reply.

Archives of internal medicine·2017

Same journal

Heparin Side Effects-Reply.

Archives of internal medicine·2017

Same journal

Humanizing primary care medicine begins with stress.

Archives of internal medicine·2017

Same journal

Legend omitted and number misrepresented.

Archives of internal medicine·2013

See all related articles

Amrinone (a new inotropic and vasodilator agent) can cause thrombocytopenia (low platelet counts) in some patients. This side effect is usually mild and does not necessitate stopping treatment if monitored closely.

Area of Science:

Pharmacology
Hematology
Cardiology

Background:

Amrinone is a novel inotropic and vasodilator medication.
Thrombocytopenia is a potential adverse effect of various medications.

Purpose of the Study:

To evaluate the frequency and characteristics of amrinone-induced thrombocytopenia.
To determine the clinical significance and management of this side effect.

Main Methods:

Prospective evaluation of 43 patients receiving amrinone.
Monitoring of platelet counts and associated clinical features.
Measurement of platelet-associated IgG levels.

Main Results:

Eight patients (18.6%) developed thrombocytopenia.

Related Experiment Videos

Thrombocytopenia was linked to accelerated peripheral platelet loss.

A dose-dependent relationship was observed for onset and severity.

Elevated platelet-associated IgG was noted, but the mechanism appeared non-immunologic.

Bleeding did not occur, and thrombocytopenia was generally mild.

Conclusions:

Amrinone can cause mild to moderate thrombocytopenia, likely via a direct effect on platelets.
Close monitoring of platelet counts is recommended.
Discontinuation of amrinone is not always necessary for mild to moderate thrombocytopenia.